The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Protective vascular and myocardial effects of adiponectin
Open accessAbstract
Adiponectin is an abundant plasma protein secreted from adipocytes that elicits protective effects in the vasculature and myocardium. In obesity and insulin-resistant states, adiponectin levels are reduced and loss of its protective effects might contribute to the excess cardiovascular risk observed in these conditions. Adiponectin ameliorates the progression of macrovascular disease in rodent models, consistent with its correlation with improved vascular outcomes in epidemiological studies. The mechanisms of adiponectin signaling are multiple and vary among its cellular sites of action. In endothelial cells, adiponectin enhances production of nitric oxide, suppresses production of reactive oxygen species, and protects cells from inflammation that results from exposure to high glucose levels or tumor necrosis factor, through activation of AMP-activated protein kinase and cyclic AMP-dependent protein kinase (also known as protein kinase A) signaling cascades. In the myocardium, adiponectin-mediated protection from ischemia–reperfusion injury is linked to cyclo-oxygenase-2-mediated suppression of tumor necrosis factor signaling, inhibition of apoptosis by AMP-activated protein kinase, and inhibition of excess peroxynitrite-induced oxidative and nitrative stress. In this Review, we provide an update of studies of the signaling effects of adiponectin in endothelial cells and cardiomyocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Reduced adiponectin levels also correlate with increased measures of systemic oxidant stress”
BackgroundThe Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041591798 · Cited by 1,985
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,134
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., & Scherer, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207198200 · Cited by 1,086
Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., Ohashi, K., Sakai, N., Shimomura, I., Kobayashi, H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000042707.50032.19 · Cited by 1,030
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., & Quon, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307878200 · Cited by 993
Shibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., & Walsh, K. (2005) · Nature Medicine · doi:10.1038/nm1295 · Cited by 982
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis
Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209033200 · Cited by 911
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin
Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T.-S., & Lodish, H. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403382101 · Cited by 859
Role of Adiponectin in Preventing Vascular Stenosis
Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206083200 · Cited by 811
Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759 · cited 1×
“AMP kinase also mediates at least some of the vascular effects of adiponectin in endothelial cells, especially those involving eNOS activation”
BackgroundBråkenhielm, E., Veitonmäki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., Funahashi, T., & Cao, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308671100 · Cited by 732
Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin
Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K., Kumada, M., Abe, Y., Funahashi, T., & Matsuzawa, Y. (2004) · Circulation Research · doi:10.1161/01.res.0000119921.86460.37 · Cited by 658
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Self-citationAdiponectin regulates albuminuria and podocyte function in mice
Sharma, K., RamachandraRao, S., Qiu, G., Usui, H. K., Zhu, Y., Dunn, S. R., Ouedraogo, R., Hough, K., McCue, P., Chan, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32691 · Cited by 612
Self-citationAssociation of Hypoadiponectinemia With Impaired Vasoreactivity
Ouchi, N., Ohishi, M., Kihara, S., Funahashi, T., Nakamura, T., Nagaretani, H., Kumada, M., Ohashi, K., Okamoto, Y., Nishizawa, H., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000083488.67550.b8 · Cited by 590
An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls
Okamoto, Y., Arita, Y., Nishida, M., Muraguchi, M., Ouchi, N., Takahashi, M., Igura, T., Inui, Y., Kihara, S., Nakamura, T., et al. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978586 · Cited by 568
Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes
Rask-Madsen, C., & King, G. L. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0366 · Cited by 484
Gao, F., Gao, E., Yue, T.-L., Ohlstein, E. H., Lopez, B. L., Christopher, T. A., & Ma, X.-L. (2002) · Circulation · doi:10.1161/01.cir.0000012529.00367.0f · Cited by 469
Self-citationOxidative stress and diabetic cardiovascular complications
Jay, D., Hitomi, H., & Griendling, K. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.018 · Cited by 464
Nitric Oxide as a Bifunctional Regulator of Apoptosis
Kim, Y.-M., Bombeck, C. A., & Billiar, T. R. (1999) · Circulation Research · doi:10.1161/01.res.84.3.253 · Cited by 464
Peroxynitrite Is a Major Contributor to Cytokine-Induced Myocardial Contractile Failure
Ferdinandy, P., Danial, H., Ambrus, I., Rothery, R. A., & Schulz, R. (2000) · Circulation Research · doi:10.1161/01.res.87.3.241 · Cited by 457
Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T. A., Lopez, B. L., Koch, W., Chan, L., Goldstein, B. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.666941 · Cited by 453
Self-citationAdiponectin Replenishment Ameliorates Obesity-Related Hypertension
Ohashi, K., Kihara, S., Ouchi, N., Kumada, M., Fujita, K., Hiuge, A., Hibuse, T., Ryo, M., Nishizawa, H., Maeda, N., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000222368.43759.a1 · Cited by 400
Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation
Tan, K. C. B., Xu, A., Chow, W. S., Lam, M. C. W., Ai, V. H. G., Tam, S. C. F., & Lam, K. S. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031012 · Cited by 360
Hypoadiponectinemia Is Closely Linked to Endothelial Dysfunction in Man
Shimabukuro, M., Higa, N., Asahi, T., Oshiro, Y., Takasu, N., Tagawa, T., Ueda, S., Shimomura, I., Funahashi, T., & Matsuzawa, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021883 · Cited by 347
Wang, Y., Xu, A., Knight, C., Xu, L. Y., & Cooper, G. J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200601200 · Cited by 342
Shibata, R., Ouchi, N., Kihara, S., Sato, K., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402558200 · Cited by 336 · cited 1×
“Furthermore, impaired angiogenesis in hind limbs of Adipoq −/− mice subjected to ischemic stress can be ameliorated by replenishment of adiponectin, in an AMP kinase-dependent manner”
BackgroundAdiponectin actions in the cardiovascular system
HOPKINS, T., OUCHI, N., SHIBATA, R., & WALSH, K. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 327
Waki, H., Yamauchi, T., Kamon, J., Kita, S., Ito, Y., Hada, Y., Uchida, S., Tsuchida, A., Takekawa, S., & Kadowaki, T. (2005) · Endocrinology · doi:10.1210/en.2004-1096 · Cited by 319
Motoshima, H., Wu, X., Mahadev, K., & Goldstein, B. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.049 · Cited by 308
Self-citationVascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
Zhu, W., Cheng, K. K. Y., Vanhoutte, P. M., Lam, K. S. L., & Xu, A. (2008) · Clinical Science · doi:10.1042/cs20070347 · Cited by 291
Kadowaki, T., Yamauchi, T., & Kubota, N. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.070 · Cited by 272
Ouedraogo, R., Gong, Y., Berzins, B., Wu, X., Mahadev, K., Hough, K., Chan, L., Goldstein, B. J., & Scalia, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29623 · Cited by 264
Self-citationDifferent effects of adiponectin isoforms in human monocytic cells
Neumeier, M., Weigert, J., Schäffler, A., Wehrwein, G., Müller-Ladner, U., Schölmerich, J., Wrede, C., & Buechler, C. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905521 · Cited by 255
Ouedraogo, R., Wu, X., Xu, S.-Q., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R., & Goldstein, B. J. (2006) · Diabetes · doi:10.2337/db05-1174 · Cited by 250
Self-citationHerrmann, J. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00347-9 · Cited by 226
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Frystyk, J., Tarnow, L., Krarup Hansen, T., Parving, H.-H., & Flyvbjerg, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1850-z · Cited by 223
Plasma Adiponectin Complexes Have Distinct Biochemical Characteristics
Schraw, T., Wang, Z. V., Halberg, N., Hawkins, M., & Scherer, P. E. (2008) · Endocrinology · doi:10.1210/en.2007-1561 · Cited by 216
Collins, S. P., Reoma, J. L., Gamm, D. M., & Uhler, M. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450673 · Cited by 216
Globular adiponectin upregulates nitric oxide production in vascular endothelial cells
Hattori, Y., Suzuki, M., Hattori, S., & Kasai, K. (2003) · Diabetologia · doi:10.1007/s00125-003-1224-3 · Cited by 208
Ding, G., Qin, Q., He, N., Francis, S., Hou, J., Liu, J., Ricks, E., & Yang, Q. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.04.014 · Cited by 171
Shinmura, K., Tamaki, K., Saito, K., Nakano, Y., Tobe, T., & Bolli, R. (2007) · Circulation · doi:10.1161/circulationaha.107.725697 · Cited by 170
Li, R., Wang, W.-Q., Zhang, H., Yang, X., Fan, Q., Christopher, T. A., Lopez, B. L., Tao, L., Goldstein, B. J., Gao, F., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00462.2007 · Cited by 169
Self-citationWilliams, J. K., Armstrong, M. L., & Heistad, D. D. (1988) · Circulation Research · doi:10.1161/01.res.62.3.515 · Cited by 154
Angiogenesis in atherosclerosis: gathering evidence beyond speculation
Moulton, K. S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245261.71129.f0 · Cited by 142
Modulation of the Inflammatory Response in Cardiovascular Disease
Granger, D. N., Vowinkel, T., & Petnehazy, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000123070.31763.55 · Cited by 135
Wang, X., Satoh, H., Kase, H., Suzuki, K., & Hattori, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.111 · Cited by 117
Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy
Koshimura, J., Fujita, H., Narita, T., Shimotomai, T., Hosoba, M., Yoshioka, N., Kakei, M., Fujishima, H., & Ito, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.032 · Cited by 113
Mahadev, K., Wu, X., Donnelly, S., Ouedraogo, R., Eckhart, A. D., & Goldstein, B. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn034 · Cited by 112
Self-citationAdiponectin Is Associated With Vascular Function Independent of Insulin Sensitivity
Fernández‐Real, J. M., Castro, A., Vázquez, G., Casamitjana, R., López‐Bermejo, A., Peñarroja, G., & Ricart, W. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.739 · Cited by 103
Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients
Schalkwijk, C. G., Chaturvedi, N., Schram, M. T., Fuller, J., & Stehouwer, C. D. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1117 · Cited by 100
Wu, X., Mahadev, K., Fuchsel, L., Ouedraogo, R., Xu, S., & Goldstein, B. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00115.2007 · Cited by 76
Self-citationLäutamaki, R., Rönnemaa, T., Huupponen, R., Lehtimäki, T. J., Iozzo, P., Airaksinen, J. K. E., Knuuti, J. M., & Nuutila, P. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.018 · Cited by 63
Xu, S., Mahadev, K., Wu, X., Fuchsel, L., Donnelly, S., Scalia, R. G., & Goldstein, B. J. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.163634 · Cited by 63
Self-citationIkeda, Y., Ohashi, K., Shibata, R., Pimentel, D. R., Kihara, S., Ouchi, N., & Walsh, K. X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.002 · Cited by 60
Natarajan, R., Salloum, F. N., Fisher, B. J., Kukreja, R. C., & Fowler, A. A. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31815f248d · Cited by 55
Adipokines and vascular disease in diabetes
Goldstein, B. J., & Scalia, R. G. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0006-6 · Cited by 49
Self-citationBora, P. S., Kaliappan, S., Lyzogubov, V. V., Tytarenko, R. G., Thotakura, S., Viswanathan, T., & Bora, N. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.024 · Cited by 45
Halperin, F., Beckman, J. A., Patti, M., Trujillo, M. E., Garvin, M., Creager, M. A., Scherer, P. E., & Goldfine, A. B. (2005) · Diabetologia · doi:10.1007/s00125-005-1901-5 · Cited by 40
Date, H., Imamura, T., Ideguchi, T., Kawagoe, J., Sumi, T., Masuyama, H., Onitsuka, H., Ishikawa, T., Nagoshi, T., & Eto, T. (2006) · Clinical Cardiology · doi:10.1002/clc.4960290508 · Cited by 28
Cited by
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Bastien, M., Poirier, P., Lemieux, I., & Després, J.-P. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.016 · Cited by 1,125
Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus
van den Oever, I. A. M., Raterman, H. G., Nurmohamed, M. T., & Simsek, S. (2010) · Mediators of Inflammation · doi:10.1155/2010/792393 · Cited by 363
Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders
Lehr, S., Hartwig, S., & Sell, H. (2012) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201100052 · Cited by 352
Metadata
- Authors
- Goldstein, B. J., Scalia, R. G., & Ma, X. L.
- Venue
- Nature Clinical Practice Cardiovascular Medicine
- Published
- 2008-11-25
- Volume
- 6
- Issue
- 1
- Pages
- 27-35
- ISSN
- 1743-4297 (ISSN-L)
- 1743-4300
- OpenAlex
- W2095580512
- Cited by
- 287
- References
- 70
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.